Works matching IS 09538194 AND DT 2025 AND VI 37

Results: 51
    1

    Alternative lengthening of telomeres and Ki‐67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 4, p. 1, doi. 10.1111/jne.70003
    By:
    • Gudmundsdottir, Hallbera;
    • Graham, Rondell P.;
    • Greipp, Patricia T.;
    • Habermann, Elizabeth B.;
    • Knudson, Ryan A.;
    • Brandt, Carrie A.;
    • Starlinger, Patrick;
    • Thiels, Cornelius A.;
    • Warner, Susanne G.;
    • Smoot, Rory L.;
    • Truty, Mark J.;
    • Kendrick, Michael L.;
    • Nagorney, David M.;
    • Cleary, Sean P.;
    • Halfdanarson, Thorvardur R.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Earlier diagnosis of small intestine neuroendocrine tumours (SI‐NETs) through transformation of the South Wales NET service.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 4, p. 1, doi. 10.1111/jne.13486
    By:
    • Gould, Harriet L.;
    • Amin, Kapish;
    • Karategos, Thanos;
    • Abbas, Sarah;
    • Olive, Susannah;
    • Sivananthan, Mathoorika;
    • Rela, Ayeesha;
    • Reed, Harriet;
    • Powell, Catherine;
    • Navaratnam, Janu;
    • Ellis‐Owen, Rwth;
    • Fielding, Patrick;
    • Mondal, Dipanjali;
    • Kihara, Steve;
    • Williams, Gethin;
    • Morgan, Carys;
    • Witczak, Justyna;
    • Cornish, Julie;
    • Gwynne, Sarah;
    • Horwood, James
    Publication type:
    Article
    16

    Issue Information.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 4, p. 1, doi. 10.1111/bju.16761
    Publication type:
    Article
    17

    Abstracts.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, p. 1, doi. 10.1111/jne.70018
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Issue Information.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 3, p. 1, doi. 10.1111/bju.16761
    Publication type:
    Article
    31
    32
    33

    Impact of dyslipidemia and lipid‐lowering therapy with statins in patients with neuroendocrine tumors.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 2, p. 1, doi. 10.1111/jne.13485
    By:
    • Faggiano, Antongiulio;
    • Russo, Flaminia;
    • Zamponi, Virginia;
    • Sesti, Franz;
    • Puliani, Giulia;
    • Modica, Roberta;
    • Malandrino, Pasqualino;
    • Ferraù, Francesco;
    • Rinzivillo, Maria;
    • Di Muzio, Marco;
    • Di Simone, Emanuele;
    • Panattoni, Nicolò;
    • Dolce, Pasquale;
    • Lauretta, Rosa;
    • Di Iasi, Gianfranco;
    • Prinzi, Antonio;
    • Alessi, Ylenia;
    • Feola, Tiziana;
    • Mazzilli, Rossella;
    • Appetecchia, Marialuisa
    Publication type:
    Article
    34
    35
    36
    37
    38

    Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 2, p. 1, doi. 10.1111/jne.13479
    By:
    • Prasad, Vikas;
    • Koumarianou, Anna;
    • Denecke, Timm;
    • Sundin, Anders;
    • Deroose, Christophe M.;
    • Pavel, Marianne;
    • Christ, Emanuel;
    • Lamarca, Angela;
    • Caplin, Martyn;
    • Castaño, Justo P.;
    • Dromain, Clarisse;
    • Falconi, Massimo;
    • Grozinsky‐Glasberg, Simona;
    • Hofland, Johannes;
    • Knigge, Ulrich Peter;
    • Kos‐Kudla, Beata;
    • Krishna, Balkundi A.;
    • Reed, Nicholas Simon;
    • Scarpa, Aldo;
    • Srirajaskanthan, Rajaventhan
    Publication type:
    Article
    39

    Issue Information.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 2, p. 1, doi. 10.1111/jne.13401
    Publication type:
    Article
    40
    41
    42
    43

    Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 1, p. 1, doi. 10.1111/jne.13472
    By:
    • Polici, Michela;
    • Caruso, Damiano;
    • Masci, Benedetta;
    • Marasco, Matteo;
    • Valanzuolo, Daniela;
    • Dell'Unto, Elisabetta;
    • Zerunian, Marta;
    • Campana, Davide;
    • De Santis, Domenico;
    • Lamberti, Giuseppe;
    • Iannicelli, Elsa;
    • Prosperi, Daniela;
    • Annibale, Bruno;
    • Laghi, Andrea;
    • Panzuto, Francesco;
    • Rinzivillo, Maria
    Publication type:
    Article
    44

    Screening and surveillance practices for Multiple Endocrine Neoplasia type 1‐related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)—An ENETS MEN1 task force questionnaire study.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 1, p. 1, doi. 10.1111/jne.13468
    By:
    • Pieterman, Carolina R. C.;
    • Grozinsky‐Glasberg, Simona;
    • O'Toole, Dermot;
    • Howe, James R.;
    • Ambrosini, Valentina;
    • Belli, Susana H.;
    • Andreassen, Mikkel;
    • Begum, Nehara;
    • Denecke, Timm;
    • Faggiano, Antongiulio;
    • Falconi, Massimo;
    • Grey, Jo;
    • Knigge, Ulrich P.;
    • Kolarova, Teodora;
    • Niederle, Bruno;
    • Nieveen van Dijkum, Els;
    • Partelli, Stefano;
    • Pascher, Andreas;
    • Rindi, Guido;
    • Ruszniewski, Philippe
    Publication type:
    Article
    45

    Cognitive decline in Cushing's syndrome: A systematic review.

    Published in:
    Journal of Neuroendocrinology, 2025, v. 37, n. 1, p. 1, doi. 10.1111/jne.13466
    By:
    • Katragadda, Anila;
    • Kunadia, Jessica;
    • Kirsch, Polly;
    • Dorcely, Brenda;
    • Shah, Shruti;
    • Henig, Zachary;
    • Job, Asha;
    • Feelders, Richard A.;
    • Agrawal, Nidhi
    Publication type:
    Article
    46
    47
    48
    49
    50